Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009191. doi: 10.1002/14651858.CD009191.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(6):CD009191.

PMID:
23543572
2.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2015 Jun 4;(6):CD009191. doi: 10.1002/14651858.CD009191.pub3. Review.

PMID:
26041152
3.

A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia.

Foucan L, Bourhis V, Bangou J, Mérault L, Etienne-Julan M, Salmi RL.

Am J Med. 1998 Apr;104(4):339-42.

PMID:
9576406
4.

Zinc supplements for treating thalassaemia and sickle cell disease.

Swe KM, Abas AB, Bhardwaj A, Barua A, Nair NS.

Cochrane Database Syst Rev. 2013 Jun 28;(6):CD009415. doi: 10.1002/14651858.CD009415.pub2. Review.

PMID:
23807756
5.

Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.

Asnani MR, Quimby KR, Bennett NR, Francis DK.

Cochrane Database Syst Rev. 2016 Oct 6;10:CD011175. Review.

PMID:
27711980
6.

Folate supplementation in people with sickle cell disease.

Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, Stover PJ.

Cochrane Database Syst Rev. 2016 Feb 16;2:CD011130. doi: 10.1002/14651858.CD011130.pub2. Review.

7.

Vitamin D supplementation for sickle cell disease.

Soe HH, Abas AB, Than NN, Ni H, Singh J, Said AR, Osunkwo I.

Cochrane Database Syst Rev. 2017 Jan 20;1:CD010858. doi: 10.1002/14651858.CD010858.pub2. Review.

PMID:
28105733
10.

Laser therapy for retinopathy in sickle cell disease.

Myint KT, Sahoo S, Thein AW, Moe S, Ni H.

Cochrane Database Syst Rev. 2015 Oct 9;(10):CD010790. doi: 10.1002/14651858.CD010790.pub2. Review.

PMID:
26451693
11.

Pentoxifylline for diabetic kidney disease.

Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006800. doi: 10.1002/14651858.CD006800.pub2. Review.

PMID:
22336824
12.

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

Li EC, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2014 Aug 22;(8):CD009096. doi: 10.1002/14651858.CD009096.pub2. Review.

PMID:
25148386
13.

Treatment for osteoporosis in people with ß-thalassaemia.

Bhardwaj A, Swe KM, Sinha NK, Osunkwo I.

Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2. Review.

PMID:
26964506
14.

Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.

van Zuuren EJ, Fedorowicz Z.

Cochrane Database Syst Rev. 2015 Dec 18;(12):CD010155. doi: 10.1002/14651858.CD010155.pub3. Review.

PMID:
26684281
15.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
16.

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.

Musini VM, Nazer M, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2014 May 29;(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Review.

PMID:
24869750
17.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

18.

Treatment for avascular necrosis of bone in people with sickle cell disease.

Martí-Carvajal AJ, Solà I, Agreda-Pérez LH.

Cochrane Database Syst Rev. 2012 May 16;(5):CD004344. doi: 10.1002/14651858.CD004344.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;(7):CD004344.

PMID:
22592696
19.

Treatment for avascular necrosis of bone in people with sickle cell disease.

Martí-Carvajal AJ, Solà I, Agreda-Pérez LH.

Cochrane Database Syst Rev. 2014 Jul 10;(7):CD004344. doi: 10.1002/14651858.CD004344.pub5. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD004344.

PMID:
25009086
20.

Treatment for avascular necrosis of bone in people with sickle cell disease.

Martí-Carvajal AJ, Solà I, Agreda-Pérez LH.

Cochrane Database Syst Rev. 2016 Aug 9;(8):CD004344. doi: 10.1002/14651858.CD004344.pub6. Review.

PMID:
27502327

Supplemental Content

Support Center